PL4125881T3 - Nowe zastosowanie agonisty receptora angiotensyny ii typu 2 - Google Patents

Nowe zastosowanie agonisty receptora angiotensyny ii typu 2

Info

Publication number
PL4125881T3
PL4125881T3 PL21715306.3T PL21715306T PL4125881T3 PL 4125881 T3 PL4125881 T3 PL 4125881T3 PL 21715306 T PL21715306 T PL 21715306T PL 4125881 T3 PL4125881 T3 PL 4125881T3
Authority
PL
Poland
Prior art keywords
angiotensin
type
receptor agonist
new use
new
Prior art date
Application number
PL21715306.3T
Other languages
English (en)
Inventor
Carl-Johan Dalsgaard
Johan Raud
Rohit Batta
Original Assignee
Vicore Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2004209.9A external-priority patent/GB202004209D0/en
Priority claimed from GBGB2009574.1A external-priority patent/GB202009574D0/en
Application filed by Vicore Pharma Ab filed Critical Vicore Pharma Ab
Publication of PL4125881T3 publication Critical patent/PL4125881T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL21715306.3T 2020-03-23 2021-03-22 Nowe zastosowanie agonisty receptora angiotensyny ii typu 2 PL4125881T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB2004209.9A GB202004209D0 (en) 2020-03-23 2020-03-23 New use
GBGB2009574.1A GB202009574D0 (en) 2020-06-23 2020-06-23 New use
US17/113,416 US11123329B1 (en) 2020-03-23 2020-12-07 Use of angiotensin II type 2 receptor agonist
PCT/GB2021/050699 WO2021191592A1 (en) 2020-03-23 2021-03-22 New use of angiotensin ii type 2 receptor agonist

Publications (1)

Publication Number Publication Date
PL4125881T3 true PL4125881T3 (pl) 2024-12-02

Family

ID=77747178

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21715306.3T PL4125881T3 (pl) 2020-03-23 2021-03-22 Nowe zastosowanie agonisty receptora angiotensyny ii typu 2

Country Status (12)

Country Link
US (2) US11123329B1 (pl)
EP (1) EP4125881B1 (pl)
JP (1) JP7671305B2 (pl)
CN (1) CN115605201A (pl)
CA (1) CA3176108A1 (pl)
ES (1) ES2992423T3 (pl)
HR (1) HRP20241435T1 (pl)
HU (1) HUE068662T2 (pl)
PL (1) PL4125881T3 (pl)
RS (1) RS66072B1 (pl)
SM (1) SMT202400427T1 (pl)
WO (1) WO2021191592A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202004094D0 (en) * 2020-03-20 2020-05-06 Vicore Pharma Ab New compounds and uses
US20220233480A1 (en) * 2020-03-23 2022-07-28 Vicore Pharma Ab Use of angiotensin ii type 2 receptor agonist
IL297362A (en) * 2020-04-22 2022-12-01 Airway Therapeutics Inc Use of surfactant protein d to treat viral infections
US20240408065A1 (en) * 2021-09-30 2024-12-12 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Cyano compound, and preparation method therefor and use thereof
CN115385983A (zh) * 2022-01-11 2022-11-25 嘉兴安谛康生物科技有限公司 氮杂双环类化合物及其制备方法、药物组合物和用途
CN114948950A (zh) * 2022-01-19 2022-08-30 广州谷森制药有限公司 一种药物组合物及其抗病毒用途
AU2024208969A1 (en) * 2023-01-16 2025-07-24 Hainan Simcere Pharmaceutical Co., Ltd. Antiviral pharmaceutical composition and preparation method therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002257970B2 (en) 2001-05-31 2007-08-02 Vicore Pharma Ab Tricyclic compounds useful as angiotensin II agonists
EP1723962A1 (en) 2005-05-19 2006-11-22 IMBA-Institut für Molekulare Biotechnologie GmbH Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries
AU2016227486A1 (en) 2015-03-02 2017-08-17 Vicore Pharma Ab Angiotensin ll receptor agonist for treating pulmonary fibrosis
GB201818164D0 (en) 2018-11-07 2018-12-19 Vicore Pharma Ab New composition

Also Published As

Publication number Publication date
WO2021191592A1 (en) 2021-09-30
EP4125881A1 (en) 2023-02-08
CA3176108A1 (en) 2021-09-30
HRP20241435T1 (hr) 2024-12-20
US20210290596A1 (en) 2021-09-23
SMT202400427T1 (it) 2024-11-15
CN115605201A (zh) 2023-01-13
JP2023520323A (ja) 2023-05-17
EP4125881C0 (en) 2024-07-24
US11123329B1 (en) 2021-09-21
EP4125881B1 (en) 2024-07-24
HUE068662T2 (hu) 2025-01-28
RS66072B1 (sr) 2024-11-29
ES2992423T3 (es) 2024-12-12
JP7671305B2 (ja) 2025-05-01
US20210386712A1 (en) 2021-12-16

Similar Documents

Publication Publication Date Title
HUE068662T2 (hu) Angiotenzin-ii-receptor-2 agonista új alkalmazása
HUE070119T2 (hu) GLP-1R receptor agonista vegyület és alkalmazása
IL310699B1 (en) Thr-beta receptor agonist compound and method for its preparation and use
SI3989972T1 (sl) Agonisti receptorja za glukagonu podobni peptid 1
ZA202006115B (en) Phenylpyrrolidinone formyl peptide 2 receptor agonists
ZA202102263B (en) Oral formulations of kappa opioid receptor agonists
IL290479A (en) Non-peptide somatostatin type 5 receptor agonists and their use
GB2603330B (en) Heterocyclic THR-B receptor agonist compound and preparation method and use therefor
MA31563B1 (fr) Combinaisons synergiques d'antagonistes vr-1 et d'inhibiteurs de cox-2
SG11202106716RA (en) Combination of selective alpha-adrenergic receptor agonist or an anticholinergic agent and lipoic acid and uses thereof
IL304329A (en) Use of a melanocortin-4 receptor agonist
ZA201908471B (en) New uses of a pure 5-ht 6 receptor antagonist
EP3549948A4 (en) AGONISTIC PEPTIDE FOR ADIPONECTIN RECEPTOR
IL292755A (en) Crystalline forms of c-c chemokine type 4 antagonist and its uses
ZA202006157B (en) Pharmaceutical composition of kor receptor agonist
EP3851106A4 (en) MEDICAL USES OF PROSTACYCLIN RECEPTORAGONISTS
AU2021349680A9 (en) Use of sphingosine-1-phosphate receptor agonist
GB202108483D0 (en) Modulator of g protein-coupled receptor 88
IL282364A (en) 5-HT4 receptor agonist uses
GB202020037D0 (en) Modulators of G protein-coupled receptor 88
HK40073517A (en) Prostaglandin e2 receptor 4 antagonists and uses thereof
HK40076468A (en) Use of an orexin 2 receptor agonist for the treatment of excessive sleepiness
GB202007050D0 (en) Peptide agonist
GB201700238D0 (en) Prodrugs of an angiotensin receptor agonist